Search

Solution NMR structure of 8-residue Rosetta-designed cyclic peptide D8.31 in d6-DMSO with cis/trans switching
Authors
Ramelot, T.A., Tejero, R., Montelione, G.T.
Assembly
DAL-DPR-MLU-DVA-DAL-DPR-MLU-DVA
Entity
1. DAL-DPR-MLU-DVA-DAL-DPR-MLU-DVA (polymer, Thiol state: not present), 8 monomers, 807.0290 × 2 Da
Total weight
1614.058 Da
Max. entity weight
807.029 Da
Source organism
synthetic construct
Exptl. method
solution NMR
Data set
assigned_chemical_shifts, spectral_peak_list
Chemcal Shifts
1H: 88, 13C: 72, 15N: 8 assignments Detail
IDEntity IDSeq IDComp IDAtom IDAtom typeValVal errAmbig. code
111DALH1H7.570.02
211DALCC170.50.2
311DALNN116.20.2
411DALCAC46.10.2
511DALCBC17.50.2
611DALHAH4.750.02
711DALHB1H1.150.02
812DPRCAC56.00.2
912DPRCBC29.60.2
1012DPRCDC47.50.2
1112DPRCGC25.20.2
1212DPRHAH4.650.02
1312DPRHB2H2.080.02
1412DPRHB3H1.800.02
1512DPRHD2H3.610.02
1612DPRHD3H3.430.02
1712DPRHG2H2.160.02
1812DPRHG3H1.790.02
1913MLUCC167.00.2
2013MLUCAC59.20.2
2113MLUCBC36.80.2
2213MLUCD1C23.70.2
2313MLUCD2C22.40.2
2413MLUCGC24.50.2
2513MLUCNC29.70.2
2613MLUHAH4.550.02
2713MLUHB2H1.830.02
2813MLUHB3H1.640.02
2913MLUHCN1H2.660.02
3013MLUHD11H0.910.02
3113MLUHD21H0.890.02
3213MLUHGH1.400.02
3314DVAHH7.630.02
3414DVACC170.60.2
3514DVANN114.10.2
3614DVACAC60.60.2
3714DVACBC30.40.2
3814DVACG1C19.70.2
3914DVACG2C18.90.2
4014DVAHAH4.030.02
4114DVAHBH2.000.02
4214DVAHG11H0.880.02
4314DVAHG21H0.850.02
4415DALHH7.570.02
4515DALCC170.50.2
4615DALNN116.20.2
4715DALCAC46.10.2
4815DALCBC17.50.2
4915DALHAH4.750.02
5015DALHB1H1.150.02
5116DPRCAC56.00.2
5216DPRCBC29.60.2
5316DPRCDC47.50.2
5416DPRCGC25.20.2
5516DPRHAH4.650.02
5616DPRHB2H2.080.02
5716DPRHB3H1.800.02
5816DPRHD2H3.610.02
5916DPRHD3H3.430.02
6016DPRHG2H2.160.02
6116DPRHG3H1.790.02
6217MLUCC170.00.2
6317MLUCAC59.20.2
6417MLUCBC36.80.2
6517MLUCD1C23.70.2
6617MLUCD2C22.40.2
6717MLUCGC24.50.2
6817MLUCNC29.70.2
6917MLUHAH4.550.02
7017MLUHB2H1.830.02
7117MLUHB3H1.640.02
7217MLUHCN1H2.660.02
7317MLUHD11H0.910.02
7417MLUHD21H0.890.02
7517MLUHGH1.4070.02
7618DVAHH7.630.02
7718DVACC171.00.2
7818DVANN114.10.2
7918DVACAC60.60.2
8018DVACBC30.40.2
8118DVACG1C19.70.2
8218DVACG2C18.90.2
8318DVAHAH4.030.02
8418DVAHBH2.000.02
8518DVAHG11H0.880.02
8618DVAHG21H0.850.02
8711DALH1H7.360.02
8811DALNN114.10.2
8911DALCAC47.60.2
9011DALCBC17.00.2
9111DALHAH4.600.02
9211DALHB1H1.170.02
9312DPRCAC56.50.2
9412DPRCBC29.20.2
9512DPRCDC47.30.2
9612DPRCGC25.30.2
9712DPRHAH4.820.02
9812DPRHB2H2.060.02
9912DPRHB3H1.730.02
10012DPRHD2H3.590.02
10112DPRHD3H3.450.02
10212DPRHG2H2.130.02
10312DPRHG3H1.890.02
10413MLUCC169.80.2
10513MLUCAC59.00.2
10613MLUCBC36.30.2
10713MLUCD1C24.00.2
10813MLUCD2C22.50.2
10913MLUCGC24.40.2
11013MLUCNC29.30.2
11113MLUHAH4.700.02
11213MLUHB2H1.810.02
11313MLUHB3H1.630.02
11413MLUHCN1H2.600.02
11513MLUHD11H0.910.02
11613MLUHD21H0.890.02
11713MLUHGH1.320.02
11814DVAHH8.430.02
11914DVANN115.60.2
12014DVACAC61.00.2
12114DVACBC30.60.2
12214DVACG1C19.60.2
12314DVACG2C19.20.2
12414DVAHAH4.010.02
12514DVAHBH2.030.02
12614DVAHG11H0.850.02
12714DVAHG21H0.860.02
12815DALHH7.350.02
12915DALNN117.30.2
13015DALCAC46.10.2
13115DALCBC18.20.2
13215DALHAH4.760.02
13315DALHB1H1.130.02
13416DPRCAC57.60.2
13516DPRCBC29.120.2
13616DPRCDC48.10.2
13716DPRCGC25.30.2
13816DPRHAH4.610.02
13916DPRHB2H2.220.02
14016DPRHB3H1.760.02
14116DPRHD2H3.670.02
14216DPRHD3H3.670.02
14316DPRHG2H2.060.02
14416DPRHG3H1.890.02
14517MLUCAC68.40.2
14617MLUCBC38.30.2
14717MLUCD1C23.50.2
14817MLUCD2C22.10.2
14917MLUCGC25.30.2
15017MLUCNC40.90.2
15117MLUHAH3.700.02
15217MLUHB2H2.220.02
15317MLUHB3H1.660.02
15417MLUHCN1H3.220.02
15517MLUHD11H0.870.02
15617MLUHD21H0.880.02
15717MLUHGH1.420.02
15818DVAHH7.960.02
15918DVACC170.80.2
16018DVANN112.30.2
16118DVACAC60.20.2
16218DVACBC31.30.2
16318DVACG1C19.50.2
16418DVACG2C18.40.2
16518DVAHAH4.010.02
16618DVAHBH1.840.02
16718DVAHG11H0.840.02
16818DVAHG21H0.770.02

Release date
2022-04-17
Citation
Accurate de novo design of membrane-traversing macrocycles
Bhardwaj, G., O'Connor, J., Rettie, S., Huang, Y.H., Ramelot, T.A., Mulligan, V.K., Alpkilic, G.G., Palmer, J., Bera, A.K., Bick, M., Di Piazza, M., Li, X., Hosseinzadeh, P., Craven, T.W., Tejero, R., Lauko, A., Choi, R., Glynn, C., Dong, L.L., Griffin, R., van Voorhis, W., Rodriguez, J., Stewart, L., Montelione, G.T., Craik, D., Baker, D.
Cell (2022), 185, 3520-3532, PubMed 36041435 , DOI 10.1016/j.cell.2022.07.019 ,
Experiments performed 9 experiments Detail
Chemical shift validation 3 contents Detail
Keywords DE NOVO PROTEIN, cis/trans, cyclic peptide, de novo design, membrane permeability, non natural amino acids, switch peptides